Journal of Veterinary Internal Medicine · 1994 · 99 citations · 7 references
PharmacyOncologyPharmacotherapyOncology PharmacotherapySolid Tumor PharmacotherapyTumor ImmunologyMalignant NeoplasmsMast Cell PharmacologyClinical RemissionMast Cell BiologyMast Cell TherapeuticsPrednisone Use
Twenty-five dogs with naturally occurring mast cell tumors were treated with daily oral prednisone (1 mg/kg) for 28 days. Five dogs (20%) had reduction in tumor volume and were considered responders. Four of these underwent partial remission and one underwent complete remission. Survival times for the five responders were 3, 5, 6, 7.5, and greater than 28 months, respectively. We therefore conclude that prednisone is effective in some canine mast cell tumors. Further studies are indicated to determine the most effective dose of prednisone, the appropriate duration of treatment, and the efficacy in more benign mast cell tumors, and in combination with other forms of therapy.
7
Annals of Internal Medicine · 1992 · 793 citations
Medicine, Oncology, Pharmacology +17
How large should a phase II trial of a new drug be?
Ronald Simon · PubMed · 1987 · 98 citations
Medicine, Oncology, Pharmacology +17